Our and other studies have shown that IL2 plays an important role in anti-Mtb infection, significantly reducing the bacterial burden in the lungs of multidrug-resistant tuberculosis (MDR-TB)-infected hosts, resulting in milder pathology/lesions and improved treatment outcomes (50). The gene discussed is IL2; the disease is multidrug-resistant tuberculosis.